Eloralintide
5 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| Eloralintide for cardiovascular diseases | Trial registered, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Eloralintide for diabetes mellitus, type 2 | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 4 |
| Eloralintide for metabolic diseases | Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| Eloralintide for obesity | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 13 |
| Eloralintide for osteoarthritis | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |